In Brief: Martek Biosciences patent
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences patent: Company announces Aug. 28 that it has received a patent number for "the blending, in infant formula and nutritional supplements, of microbially-derived arachidonic acid (ARA) oil with low eicosapentaenoic acid (EPA) fish oils." Martek explains that "fish oil is a potential competitive source of docosahexaenoic acid (DHA) to Martek's algae-derived DHA oil" and that "DHA and ARA are two primary components of Martek's proprietary infant formula ingredient, Formulaid"...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning